MEDIZO · Checked.be

Summary

Conclusion

the dossier summarised in one paragraph

The computed 12-month bankruptcy probability of MEDIZO is 0.1% (very low). The 2025 annual accounts show equity of €302k and a net result of €30k. Equity is growing by ~8.8% per year across the filed fiscal years. Its solvency ranks better than 69% of 2217 sector peers (fiscal year 2025). The company has been active since 2004 and the Belgian State Gazette contains no insolvency or warning signals.

Based on the State Gazette, CBE and 7 annual accounts.

Signals

2 signals · with evidence

Consistently profitable

Positive net result in the two most recent financial years (2024 and 2025).

View the result trend

Growing equity

Equity grew over 2023-2025. Profits are largely retained rather than distributed.

View the equity trend

Signals are derived from the filed annual accounts and the sector comparison. No composite score: each signal is separately verifiable at the source.

Filing behaviour

From the deposit records, complete market-wide

Latest accounts filed on time

The financial year that closed on 30-06-2025 was due by 31-01-2026 and was filed on 30-01-2026, 1 days ahead of the deadline. This speaks to administrative punctuality and says nothing about the financial position.

The next deadline is still running

The next financial year closes on 30-06-2026 and is due by 31-01-2027. Nothing is late today.

How we compute the deadline

The year end is derived from 10 filed financial years, each closing on 30-06. The statutory deadline is seven months after the close of the financial year (art. 3:10 par. 1 CAC, art. 3:47 par. 7 for ASBL and foundations). Applied to the financial year that closed on 30-06-2025, that is 31-01-2026.

Deadline per financial year

Year closed	Due by	Filed	Variance	Reference
30-06-2025	31-01-2026	30-01-2026	1 d early	2026-00030178
30-06-2024	31-01-2025	04-02-2025	4 d late	2025-00027673
30-06-2023	31-01-2024	21-12-2023	41 d early	2023-00535842
30-06-2022	31-01-2023	31-01-2023	on the day	2023-00019106
30-06-2021	31-01-2022	11-02-2022	11 d late	2022-05600090
30-06-2020	31-01-2021	17-02-2021	17 d late	2021-05600115
30-06-2019	31-01-2020	06-01-2020	25 d early	2020-00200534
30-06-2018	31-01-2019	17-12-2018	45 d early	2018-74600023
30-06-2017	31-01-2018	31-01-2018	on the day	2018-03400211
30-06-2016	31-01-2017	03-01-2017	28 d early	2017-00100562

Source: the National Bank's deposit records. Those records are complete, including for years whose figures we have not read yet. Filing late covers nearly half the market and is therefore not scored; only not filing, being more than 90 days late and breaking a punctual record carry weight.

Trust signals

2 signals

Long-established

Founded in 2004, 21 years in business.

No legal incidents

No bankruptcy, reorganisation or interim measure in the Belgisch Staatsblad, and the KBO register records a normal legal situation.

Administrative Flags

No strikeouts found in the KBO publications we processed. That series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.

Bankruptcy probability (12 mo)

Checked model v1 · free for everyone

0.1% Very low

0%0,5%1,5%4%10%≥25%

Lower-failure-rate sector −Long track record −Annual accounts: healthy financial profile −

Statistical estimate based on public sources, not credit advice nor a finding of fact. How do we compute this?

Financials

TurnoverNot published (abbreviated filing)

EBIT marginNot published (abbreviated filing)

Net result€30k-56.2%

Working capital€289k+3.2%

CSV export

Annual accounts & ratios

Source: NBB · 2025

Annual accounts filed on 30-01-2026 with the NBB · fiscal year 2025 · micro

Operating resultNet result

Trajectory (indicative)

Projection over 3 fiscal years from the filed annual accounts, not a forecast, the extended trend.

growing Equity: growth of ~8.8%/year over 7 fiscal years, indicative, assuming unchanged policy.

Solid line = filed figures · dashed = extended trend · area = indicative range.

How do we compute this?

The trend is a robust median of all pairwise slopes between fiscal years (Theil-Sen), so a single odd year cannot hijack the line. For strictly positive series we also fit a log variant (compound annual growth) and keep whichever describes the figures best.

The area around the projection is 1.8 × the median absolute deviation from the trend, widening each year ahead (×1 / ×1.6 / ×2.2), with a minimum of 8% of the last value. It is an indicative range, not a statistical confidence interval.

A series whose deviations exceed 35% of its level is too volatile: we then deliberately show no projection. Every projection assumes unchanged policy and is blind to non-public information (order book, contracts, funding rounds).

Sector comparison

Fiscal year 2025 · NACE 86, Human health · compared within the same schema type (micro schema)

Metric	This company	Sector median	Position in the sector
Solvency	78.9%	58.2%	better than 69% of 2217 sector peers
Net result	€30k	€60k	better than 29% of 2215 sector peers
Equity	€302k	€74k	better than 88% of 2217 sector peers
Gross operating margin	€38k	€95k	better than 20% of 2217 sector peers
Total assets	€382k	€186k	better than 78% of 2217 sector peers

Median and position computed from NBB annual accounts filed by sector peers; own figures from the latest filed accounts.

Sector position over time

Percentile per fiscal year versus peers that filed figures, computed year by year (a year without enough peers is absent).

Solvency P69

Improving position over 2020-2025 · n=652-6582

Net result P29

Stable position over 2020-2025 · n=653-6576

Equity P88

Stable position over 2020-2025 · n=652-6582

Gross operating margin P20

Weakening position over 2020-2025 · n=653-6584

Describes the position versus peers, not a forecast.

EBITDA

€34k

-57.7% 19-25

Net profit

€30k

-56.2% 19-25

Cash flow

€34k

-51.7% 19-25

Total assets

€382k

+11.6% 19-25

Equity

€302k

+5.5% 19-25

Working capital

€289k

+3.2% 19-25

Employees (FTE)

2

-28.6% 19-25

Staff costs

€-519

- 19-25

Income taxes

€14k

-38.9% 19-25

Dividends

€14k

-40.3% 19-25

Debt

€80k

+42.9% 19-25

Debt ≤ 1y

€47k

-16.6% 19-25

Debt > 1y

€34k

+83.3% 19-25

Current ratio

7.16

+19.8% 19-25

Quick ratio

7.16

+19.8% 19-25

Solvency

78.9%

-5.5% 19-25

Debt / equity

0.27

+35.5% 19-25

ROE

9.9%

-58.4% 19-25

ROA

7.8%

-60.7% 19-25

Interest coverage

12.25

-77.5% 19-25

Figures by fiscal year

Highlight YoY changes (±10%)

Fiscal year	2025
Deposit	micro
Revenue	-
EBITDA	€34k
Net profit	€30k
Cash flow	€34k
Staff costs	-
Income taxes	€14k
Dividends	€14k
Total assets	€382k
Equity	€302k
Debt	€80k
of which ≤ 1y	€47k
of which > 1y	€34k
Working capital	€289k
Employees (FTE)	-

Ratios (computed)

	2025
Current ratio	7.16
Quick ratio	7.16
Working capital ratio	75.8%
Solvency	78.9%
Debt / equity	0.27
Long-term debt ratio	0.11
Interest coverage	12.25
Gross margin	-
Net margin	-
ROA	7.8%
ROE	9.9%
EBITDA margin	-
Days sales outstanding	-
Days payable outstanding	-
Inventory turnover	-
Days inventory (DSI)	-

Balance-sheet composition 2025

Assets

Fixed assets €46k · 11.9% Current assets €336k · 88.1%

Equity & liabilities

Equity €302k · 78.9% Debt €80k · 21.1%

Full annual accounts

Filed balance sheet and income statement, exactly as deposited with the NBB.

Line item	Code	2025
Balance sheet, Assets
TOTAL ASSETS	20/58	€382k
Fixed assets	21/28	€46k
Tangible fixed assets	22/27	€46k
Current assets	29/58	€336k
Amounts receivable within one year	40/41	€269k
Cash & bank	54/58	€17k
Balance sheet, Equity & liabilities
TOTAL EQUITY & LIABILITIES	10/49	€382k
Equity	10/15	€302k
Contributions / capital	10/11	€12k
Reserves	13	€289k
Amounts payable	17/49	€80k
Amounts payable after one year	17	€34k
Amounts payable within one year	42/48	€47k
Trade debts payable within one year	44	€809
Income statement
Gross operating margin	9900	€38k
Operating result	9901	€31k
Financial income	75	€17k
Financial charges	65	€3k
Result before taxes	9903	€44k
Income taxes	67/77	€14k
Net result for the period	9904	€30k
Result to be appropriated	9905	€30k

This table shows the latest fiscal year. 4 prior years, with figures and ratios, belong to a paid plan. See plans →

Ratios computed by Checked.

Health barometer

FY 2025 · computed

86 / 100 Excellent

050100

Computed from 5 of the 6 factors this model weighs. The rest cannot be derived from the filed figures, or need a prior year to compare against.

The full score breakdown, per-year score history and the indicative credit limit are in Kantoor S.

See plans →

Computed by Checked from the NBB filing for FY 2025. Indicative, not credit advice.

Structure & network

Locations & real estate

Registered office

from the Crossroads Bank

Cannot be placed on the map

This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.

Natendries 159700 Oudenaarde

Establishment units

1 location

medizo

Natendries 15, 9700 OudenaardeVerpleegkundige activiteiten

since 20082.168.354.331

Physical sites registered in the Crossroads Bank for Enterprises (CBE).

Parcels1

Ground area1,423 m²

Buildings1

Building footprint379 m²

Volume (LiDAR)1,537 m³

Tallest building6.1 m · ±1 fl.

Real-estate footprint

Source: CBE × cadastre · address linking

Parcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.

Flanders 1 (100%)

Parcel (capakey)	Region	Area	Buildings	Height / fl.
45021A1740/00B000	Flanders	1,423 m²	1 · 379 m²	6.1 m · 1 fl.

Methodology

via registered seat: 1

1 of 1 parcels with an exact address match; the rest are indicative.

Linked through address data, this is not proof of ownership.

Publications

Lifecycle & Insolvency Signals

No insolvency signals in the Belgian State Gazette

Belgisch Staatsblad · acts

1 acts

Address history · 1

27-04-2023

Registered-office move

All acts · 1 updated 3 years ago

2023

27-04-2023 Registered office moved within Oudenaarde Registered-office change·Speliers Ann

Stuivegemstraat 40, 9700 Oudenaarde → Natendries 15, 9700 Oudenaarde

Notary: Speliers Ann · Oudenaarde

Original publication ↗

Analysis

Snowflake analysis

financial profile on 5 axes

78 / 100

Exceptional profile, strong across almost every axis.

All 5 axes are computed from data Checked has read.

Health 86

Profitability 50

Solvency 100

Growth 52

Stability 100

Credit advice

verdict per customer and amount

Similar

Similar companies

Comparable size, same sector

LES SOIGNANTS UNIS

BE 0795.662.690 · Anderlecht

Eq €302k→

Evacare

BE 0754.878.645 · Harelbeke

Eq €300k→

VOCATIO

BE 0762.591.432 · Beveren-Kruibeke-Zwijndrecht

Eq €296k→

CROCHELET CATHERINE

BE 0778.282.567 · Pont-à-Celles

Eq €278k→

JP MEDICO

BE 0430.791.945 · Binche

Eq €274k→

We hold annual accounts for 734 of the 5,947 companies in this sector. 411 of them are within a factor 10 of this company's equity.

See full sector →

Company registry

Company registry (CBE)

Crossroads Bank

Activities

Verpleegkundige activiteiten86906Activiteiten van verpleegkundigen en verloskundigen86940Schoonheidsverzorging96022Schoonheidsverzorging en andere schoonheidsbehandelingen96220

Primary activity highlighted.

Names & trade names

Legal nameNL

MEDIZO

Registered office

Natendries 15

9700 Oudenaarde, Belgium

Official data from the Crossroads Bank for Enterprises (CBE). Available for every registered company.